IVF provider Virtus Health's share price has risen 57% since its low last August and is up 15% since Australia's 9,000 missing babies from 6 Apr 16 (Buy – $6.22). The stock now sports a price-earnings ratio of 17 based on 2016 estimates and a dividend yield of 3.9%. Virtus benefits from economies of scale, has plenty of free cash flow and decent growth prospects, but having brushed past our recommended Buy price, we're downgrading to HOLD.
Note: The Intelligent Investor Growth Portfolio and Equity Income Portfolio own shares in Virtus Health. You can find out about investing directly in Intelligent Investor and InvestSMART portfolios by clicking here.